We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Pediatric Drug Rule Produces Mixed Results, Report Says
EU Pediatric Drug Rule Produces Mixed Results, Report Says
An EU regulation meant to boost pediatric drug development has led to more medicines for children since it was adopted, although actual use of new products has not increased at the same pace, a European Commission report said.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor